LigaSureTM vessel sealing device
DeviceDevice will be used to clamp, cauterize, seal, and transect tissue during vaginal hysterectomy.
Other names: LigaSure, LigaSureTM, Electrosurgical sealing device
NCT Number: NCT05192954
This study will investigate pain outcomes for patients undergoing vaginal hysterectomy with pelvic reconstructive surgery using the LigasureTM vessel sealing device as compared to conventional clamping and suturing methods.
Looking for future studies?
Notify Me18 year–80 year
Female
Interventional
Not applicable
Bethesda North Hospital, Cincinnati, Ohio, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Device will be used to clamp, cauterize, seal, and transect tissue during vaginal hysterectomy.
Other names: LigaSure, LigaSureTM, Electrosurgical sealing device
Time frame: 3-6 hours postoperative
Visual Analog Scale, 0-10, with 10 being "most severe pain"
Time frame: 3-6 hours postoperative
Visual Analog Scale, 0-10, with 10 being "most severe pain"
Time frame: 3-6 hours postoperative
Visual Analog Scale, 0-10, with 10 being "most severe pain"
Marlana McDowell
Other
Comparing Postoperative Pain After LigaSureTM Vessel Sealing Device Versus Conventional Suturing Methods for Vaginal Hysterectomy and Pelvic Reconstructive Surgery: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02890498
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Nîmes, France
View Trial DetailsNCT06532292
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Taipei, Taiwan
View Trial DetailsNCT07554651
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Dnipro, Ukraine
View Trial DetailsNCT07552337
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Diyarbakır, Turkey (Türkiye)
View Trial Details